Oertel W - Search Results

1

One-year treatment with standard and sustained-release levodopa: appropriate long-term treatment of restless legs syndrome?

Trenkwalder C, Collado Seidel V, Kazenwadel J, Wetter TC, Oertel W, Selzer R, Kohnen R. Trenkwalder C, et al. Among authors: oertel w. Mov Disord. 2003 Oct;18(10):1184-9. doi: 10.1002/mds.10503. Mov Disord. 2003. PMID: 14534925 Clinical Trial.

2

Clinical symptomatology and treatment of restless legs syndrome and periodic limb movement disorder.

Stiasny K, Oertel WH, Trenkwalder C. Stiasny K, et al. Sleep Med Rev. 2002 Aug;6(4):253-65. doi: 10.1053/smrv.2001.0193. Sleep Med Rev. 2002. PMID: 12531131 Review.

3

Cabergoline versus levodopa monotherapy: a decision analysis.

Smala AM, Spottke EA, Machat O, Siebert U, Meyer D, Köhne-Volland R, Reuther M, DuChane J, Oertel WH, Berger KB, Dodel RC. Smala AM, et al. Mov Disord. 2003 Aug;18(8):898-905. doi: 10.1002/mds.10465. Mov Disord. 2003. PMID: 12889079

4

Normal dopaminergic and serotonergic metabolites in cerebrospinal fluid and blood of restless legs syndrome patients.

Stiasny-Kolster K, Möller JC, Zschocke J, Bandmann O, Cassel W, Oertel WH, Hoffmann GF. Stiasny-Kolster K, et al. Among authors: oertel wh. Mov Disord. 2004 Feb;19(2):192-6. doi: 10.1002/mds.10631. Mov Disord. 2004. PMID: 14978675

5

Patch application of the dopamine agonist rotigotine to patients with moderate to advanced stages of restless legs syndrome: a double-blind, placebo-controlled pilot study.

Stiasny-Kolster K, Kohnen R, Schollmayer E, Möller JC, Oertel WH; Rotigotine Sp 666 Study Group. Stiasny-Kolster K, et al. Mov Disord. 2004 Dec;19(12):1432-8. doi: 10.1002/mds.20251. Mov Disord. 2004. PMID: 15390055 Clinical Trial.

6

Long-term efficacy and safety of pramipexole in advanced Parkinson's disease: results from a European multicenter trial.

Möller JC, Oertel WH, Köster J, Pezzoli G, Provinciali L. Möller JC, et al. Mov Disord. 2005 May;20(5):602-10. doi: 10.1002/mds.20397. Mov Disord. 2005. PMID: 15726540 Clinical Trial.

7

Pergolide versus levodopa monotherapy in early Parkinson's disease patients: The PELMOPET study.

Oertel WH, Wolters E, Sampaio C, Gimenez-Roldan S, Bergamasco B, Dujardin M, Grosset DG, Arnold G, Leenders KL, Hundemer HP, Lledó A, Wood A, Frewer P, Schwarz J. Oertel WH, et al. Mov Disord. 2006 Mar;21(3):343-53. doi: 10.1002/mds.20724. Mov Disord. 2006. PMID: 16211594 Clinical Trial.

8

Sudden onset of sleep and dopaminergic therapy in patients with restless legs syndrome.

Möller JC, Körner Y, Cassel W, Meindorfner C, Krüger HP, Oertel WH, Stiasny-Kolster K. Möller JC, et al. Among authors: oertel wh. Sleep Med. 2006 Jun;7(4):333-9. doi: 10.1016/j.sleep.2005.08.009. Epub 2006 Mar 22. Sleep Med. 2006. PMID: 16554184

9

Validation of the "L-DOPA test" for diagnosis of restless legs syndrome.

Stiasny-Kolster K, Kohnen R, Möller JC, Trenkwalder C, Oertel WH. Stiasny-Kolster K, et al. Mov Disord. 2006 Sep;21(9):1333-9. doi: 10.1002/mds.20969. Mov Disord. 2006. PMID: 16705685

10

Controlled withdrawal of pramipexole after 6 months of open-label treatment in patients with restless legs syndrome.

Trenkwalder C, Stiasny-Kolster K, Kupsch A, Oertel WH, Koester J, Reess J. Trenkwalder C, et al. Mov Disord. 2006 Sep;21(9):1404-10. doi: 10.1002/mds.20983. Mov Disord. 2006. PMID: 16755554 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

868 results

Search Page

Filters